We help people live healthy lives in a healthy world.
Our priority is to provide access to effective treatment, and this is the basis of the company’s business strategy as well as its approach to sustainability. We ensure drug safety for patients through an uninterrupted supply of essential products, including life-saving drugs.
One in eight medicine packages sold by Polish pharmacies and every third package used in hospitals come from Polpharma. This shows our success, but also the magnitude of the commitment.
The goals of the Sustainable Development Strategy 2022–2025 allow us to responsibly manage our economic, social and environmental impact as well as generate value for our stakeholders.
Sustainability management structure
The key body that oversees sustainability and ESG issues is the company’s Sustainable Development Committee. Its tasks include strategic oversight, risk management, developing recommendations and internal policies, and setting and reviewing impact goals and indicators.
The Committee is headed by a member of the Management Board – the Head of the Finance Department, and its members are the other members of the Board and the heads of the company’s key business areas.
Polpharma’s Sustainable Development and ESG Department is responsible for the day-to-day coordination of ESG tasks, including the reporting process.